Whereas, phospho-tau has been demonstrated to contribute to dementia pathology due to its prion-like seeding activity [93,94,95,96], which allows the aberrantly phosphorylated tau aggregates to spread to as-yet unaffected brain regions, thus advancing the clinical symptoms. The gene discussed is MAPT; the disease is dementia.